Baird Upgrades Amedisys (AMED) to Neutral
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 22 | New: 15
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 22 | New: 15
Join SI Premium – FREE
Baird upgraded Amedisys (NASDAQ: AMED) from Underperform to Neutral with a price target of $10.00.
For an analyst ratings summary and ratings history on Amedisys click here. For more ratings news on Amedisys click here.
Shares of Amedisys closed at $10.17 yesterday.
For an analyst ratings summary and ratings history on Amedisys click here. For more ratings news on Amedisys click here.
Shares of Amedisys closed at $10.17 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Susquehanna Upgrades CSX (CSX) to Positive
- UBS Upgrades UL Solutions Inc (ULS) to Buy
- UBS Upgrades Rural Funds Group (RFF:AU) (RFNDF) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
